{
  "id": "6273a317e764a53204000049",
  "type": "summary",
  "question": "What links lipid metabolism pathways to ALS?",
  "ideal_answer": "Dysregulation of lipid metabolism is observed early in the spinal cord of the SOD1 ALS mouse model, and abnormal levels of cholesterol and other lipids are observed in the blood and CNS of ALS patients. In addition, higher blood high density lipoprotein and apolipoprotein A1 levels are associated with reduced risk of developing ALS.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/33113361",
    "http://www.ncbi.nlm.nih.gov/pubmed/34518331",
    "http://www.ncbi.nlm.nih.gov/pubmed/24600344",
    "http://www.ncbi.nlm.nih.gov/pubmed/31406145",
    "http://www.ncbi.nlm.nih.gov/pubmed/20362558",
    "http://www.ncbi.nlm.nih.gov/pubmed/33905537",
    "http://www.ncbi.nlm.nih.gov/pubmed/34343139",
    "http://www.ncbi.nlm.nih.gov/pubmed/33332650",
    "http://www.ncbi.nlm.nih.gov/pubmed/28870551",
    "http://www.ncbi.nlm.nih.gov/pubmed/34469619",
    "http://www.ncbi.nlm.nih.gov/pubmed/29904341",
    "http://www.ncbi.nlm.nih.gov/pubmed/32962914",
    "http://www.ncbi.nlm.nih.gov/pubmed/29410613",
    "http://www.ncbi.nlm.nih.gov/pubmed/34623437",
    "http://www.ncbi.nlm.nih.gov/pubmed/33707063",
    "http://www.ncbi.nlm.nih.gov/pubmed/34502460",
    "http://www.ncbi.nlm.nih.gov/pubmed/32656815",
    "http://www.ncbi.nlm.nih.gov/pubmed/32927603",
    "http://www.ncbi.nlm.nih.gov/pubmed/30767689",
    "http://www.ncbi.nlm.nih.gov/pubmed/33544228",
    "http://www.ncbi.nlm.nih.gov/pubmed/31562633",
    "http://www.ncbi.nlm.nih.gov/pubmed/34782793",
    "http://www.ncbi.nlm.nih.gov/pubmed/31848577",
    "http://www.ncbi.nlm.nih.gov/pubmed/26483191"
  ],
  "snippets": [
    {
      "text": "The meta-analyses identified few lipid metabolic pathways dysregulated early that were exacerbated at symptomatic stages",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34502460",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "abnormal level of cholesterol and other lipids in the circulation and central nervous system (CNS), has been reported in ALS patients",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34469619",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Higher blood high density lipoprotein and apolipoprotein A1 levels are associated with reduced risk of developing amyotrophic lateral sclerosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34518331",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "ion of these enzymes is upstream in the pathogenesis of neurodegenerative diseases and to support this we provide new evidence that ALS risk genes are enriched with genes involved in ceramide metabolism (P=0.019, OR = 2.54, Fisher exact test). Ceramide is a product of",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34623437",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ions to lipid metabolism in neurons regulate processes linked to neurodegenerative diseases, and a link between dysfunction of lipid metabolism and ALS has also been proposed. In this review we",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33707063",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ective. Taken together, our findings highlight the potential contribution of the carnitine shuttle and lipid beta oxidation in ALS and suggest strategies for therapeutic intervention based on restoring lipid metabolism in motor ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29904341",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ing evidence suggests a link between changes in lipid metabolism and ALS. He",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26483191",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "eview, we will address the available data analyzing regarding the relationship of lipid metabolism and lipid derived- products with ALS. We will a",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31562633",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "INTRODUCTION: Converging evidence highlights that lipid metabolism plays a key role in ALS p",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28870551",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "dings indicate that cell adhesion, immune-inflammation response and lipid metabolism all play important roles in the onset of ALS. Detail",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20362558",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Medium-Chain Fatty Acids, Beta-Hydroxybutyric Acid and Genetic Modulation of the Carnitine Shuttle Are Protective in a Drosophila Model of ALS Base",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29904341",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "phic lateral sclerosis (ALS), dysfunctions in lipid metabolism and function have been identified as potential drivers of pathogenesis. In particu",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29410613",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " study analyzes the nuclear lipidome in motor neurons in ALS and examines molecular pathways linked to the major lipid alterations. Nu",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33905537",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Our findings support the increasing interest in lipid metabolism in ALS and link the disease genetics to weight loss in patients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33113361",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Finally, hypermetabolism usually found in ALS patients should be considered too since all these metabolic changes could be compensation (or the cause) of the higher energy expenditure.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33544228",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Metabolic diseases and especially diabetes mellitus (DM) have been variously related to ALS.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33544228",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "While a link between dysregulated lipid metabolism and ALS has been proposed, lipidome alterations involved in disease progression are still understudied",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31406145",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In amyotrophic lateral sclerosis (ALS), dysfunctions in lipid metabolism and function have been identified as potential drivers of pathogenesis",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29410613",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ys. We present an insight into the pathological mechanisms in ALS, confirming that lipid metabolic alterations are transcriptionally dysregulated and are central to ALS aetiology, opening new options for the treatment of these devastating condit",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34502460",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "This study analyzes the nuclear lipidome in motor neurons in ALS and examines molecular pathways linked to the major lipid alterations",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33905537",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Our findings indicate that cell adhesion, immune-inflammation response and lipid metabolism all play important roles in the onset of ALS.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20362558",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Taken together, our findings highlight the potential contribution of the carnitine shuttle and lipid beta oxidation in ALS and suggest strategies for therapeutic intervention based on restoring lipid metabolism in motor neurons.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29904341",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In particular, aberrant lipid metabolism is proposed to underlie denervation of neuromuscular junctions, mitochondrial dysfunction, excitotoxicity, impaired neuronal transport, cytoskeletal defects, inflammation and reduced neurotransmitter release.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29410613",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Growing evidence suggests a link between changes in lipid metabolism and ALS.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26483191",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Interestingly, lipidome alterations in motor cortex were mostly related to age than ALS.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31406145",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Although the mechanism leading to cholesteryl esters accumulation remains to be established, we postulate a hypothetical model based on neuroprotection of polyunsaturated fatty acids into lipid droplets in response to increased oxidative stress.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31406145",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": []
}